People who are severely immune-compromised should consider getting a third dose of a COVID-19 vaccine, a federal advisory committee said on Thursday.
Author: Karen Weintraub, USA TODAY
Why does COVID-19 impact people in different ways? Genetics play a role, study finds
A study confirms or newly identifies 13 genes that appear to play a role in susceptibility to infection or that affect the severity of illness.
Mask guidelines are confusing if you’re vaccinated against COVID-19. Experts break down the details.
CDC Director Rochelle Walensky and other experts say people vaccinated against COVID-19 are protected, but local officials may decide masks are needed.
‘It isn’t over for us’: For those with weakened immune systems, COVID-19 vaccines don’t mean the end of the pandemic
For those with compromised immune systems, health experts say ‘get vaccinated, act unvaccinated,’ as vaccines may not protect well against COVID-19.
Johnson & Johnson COVID-19 vaccine protects against virus variants, study shows
In the new study, Harvard researchers who developed the J&J COVID-19 vaccine found it protected against severe disease regardless of the variant.
It’s been 40 years since the first reported cases of AIDS. While treatments have come a long way, a vaccine remains elusive.
The parallels between AIDS/HIV and COVID-19 and the virus that causes it are stark. But the differences are striking, too.
An experimental gene therapy was little Alissa’s only hope. Now, instead of certain death, she faces an uncertain future.
A scientific vision for decades, gene therapy is finally becoming more common in the U.S., fueling optimism for the treatment of rare diseases.
Blood clots and COVID-19 vaccines: How scientists are starting to unravel the rare side effect of the J&J and AstraZeneca vaccines
Although still murky, a picture is starting to emerge about the connection between two types of COVID-19 vaccines and rare blood clots.
Blood clots and COVID-19 vaccines: How scientists are starting to unravel the rare side effect of the J&J and AstraZeneca vaccines
Although still murky, a picture is starting to emerge about the connection between two types of COVID-19 vaccines and rare blood clots.
Pfizer COVID-19 vaccine is 90% effective for at least 6 months and protects against South Africa variant, study shows
Volunteers receiving a second dose of the Pfizer-BioNTech vaccine remained more than 90% protected against symptomatic COVID-19.